Executive Search Success Story: Recruiting a Manufacturing Team for a Pharmaceutical CDMO

How JRG Partners executed a confidential, multi-role pharmaceutical manufacturing leadership retained search strategy that equipped a global contract development and manufacturing organization (CDMO) with the critical executive leaders, site manufacturing directors, and technical operations experts required to expand sterile and specialty production lines, drive operational excellence, and elevate client satisfaction.

Engagement Snapshot

Client Global contract development & manufacturing organization (CDMO) (name withheld at client’s request)
Industry Life sciences — pharmaceutical manufacturing (CDMO)
Geography Boston, New Jersey, Philadelphia, Raleigh-Durham, and key pharmaceutical and biotechnology markets
Engagement Confidential retained search — multi-role leadership mandate
Roles Searched Head of Manufacturing Operations, VP Pharmaceutical Production, Site Manufacturing Directors, Technical Operations Executives, Process Improvement Leaders, Manufacturing Excellence Directors, Facility Operations Leaders, Quality Operations Executives
Talent Assessed 550+ senior executives evaluated
Timeline Retained search successfully completed within 12 months with all mission-critical leadership placements secured

The Challenge

A global contract development and manufacturing organization (CDMO) was aggressively expanding its sterile manufacturing capabilities and specialty product lines. To successfully manage this increased multi-tenant volume, protect intricate production lines, and meet tight client delivery deadlines, the organization needed to restructure its operational management team. Leadership identified several critical market and operational pressures:

  • Intense global competition for top-tier pharmaceutical manufacturing and technical leadership talent
  • Increasing client demand for highly flexible production scalability and technical agility
  • The physical and logistical complexity of expanding sterile manufacturing environments and specialized product footprints
  • Rising international regulatory scrutiny and compliance requirements across highly sensitive therapeutic sectors
  • Unaddressed succession planning concerns and key individual dependencies within essential operational roles
  • An immediate business need for versatile executives able to drive operational excellence while maximizing B2B client satisfaction

The enterprise determined that driving its scaling initiatives required a synchronized corporate management structure spanning a Head of Manufacturing Operations, VP Pharmaceutical Production, Site Manufacturing Directors, Technical Operations Executives, Process Improvement Leaders, Manufacturing Excellence Directors, Facility Operations Leaders, and Quality Operations Executives. Successfully executing this specialized multi-role mandate required an executive search firm combining deep therapeutic production literacy with a track record of sourcing compliance-driven technical and operations talent across major life sciences corridors. For organizations evaluating how expanding operations architecture interfaces with centralized delivery networks, brick-and-mortar facility setups, or localized factory lines outside of contract development spaces, a parallel analysis can be reviewed in Pharma_Manufacturing_A_Whitelabeled.docx.

Why They Chose JRG Partners

Deep CDMO Manufacturing Specialization

Unlike generalist recruiting agencies that lack functional immersion in aseptic processing environments, localized validation metrics, and multi-tenant client governance, JRG Partners maintains dedicated search practices spanning CDMO production, sterile manufacturing, technical operations, and manufacturing excellence frameworks. Our consultants carry an intimate operational understanding of both outsourced project performance and international regulatory facility parameters.

Real Access to Passive Talent

The most capable global factory directors, process improvement architects, and lean manufacturing executives are typically fully integrated into high-performing commercial supply networks, meaning they rarely monitor traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, proprietary market intelligence, and executive networks to directly engage high-performing passive leaders invisible to standard sourcing methods.

Confidential Search Execution

Because this leadership architecture was built during an active facility expansion and production scaling phase where sensitive customer agreements, proprietary client formulations, and stakeholder confidence were at stake, absolute discretion was mandatory. JRG Partners deployed a highly secure, confidential vetting and outreach framework that successfully insulated the client’s strategic positioning, protected ongoing line continuity, and maintained total candidate trust throughout the recruitment lifecycle.

Broad Sourcing Reach

Sourcing specialized software, laboratory, and plant engineering executives capable of driving standardized performance across separate regional manufacturing facilities required an outreach strategy unconstrained by geographical borders. JRG Partners executed a coordinated talent acquisition strategy targeting top-performing leaders from CDMO, pharmaceutical, and biotechnology manufacturing organizations across primary global corridors.

Our Corporate Search Strategy

Phase 1 — Strategic Alignment & Leadership Assessment

Our consultants partnered directly with the board of directors and executive team to map existing structural gaps, identify hidden succession risks, clarify validation milestones, and define the exact leadership competencies required for long-term clinical and market integration. Rather than matching candidates against legacy job descriptions, we built forward-looking executive profiles dynamically tied to the enterprise’s long-term commercialization and multi-site scalability strategy.

Phase 2 — Multi-Sector Market Mapping

JRG Partners executed an exhaustive market-mapping initiative targeting process-driven management and compliance-focused environments globally. Our comprehensive market map targeted key talent pools across contract development and manufacturing organizations, commercial pharmaceutical manufacturers, sterile production companies, specialty pharmaceutical organizations, biotechnology manufacturers, and elite life sciences companies.

Phase 3 — Targeted Executive Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated high-achieving corporate production leaders with verified records of success in scaling CDMO facilities. Only candidates demonstrating clear, measurable operational impact and rigorous plant governance advanced to the final evaluation round.

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials. Our consultants conversion-tested strategic and functional capabilities, line agility under strict regulatory guidelines, team-building and leadership philosophies, cross-functional fluency, and long-term retention potential.

Results Delivered

JRG Partners successfully filled the multi-role mandate, providing the global CDMO with a synchronized, top-tier executive core built to support multi-site facility scalability securely.

  • Strengthened Operational Leadership: Mission-critical C-suite, vice president, and facility director positions across production lines, engineering, and quality management were successfully filled, creating a unified operations leadership framework.
  • Increased Production Capacity: Newly placed corporate and operational strategy leadership successfully optimized material workflows and resource deployment, resulting in measurably increased sterile and specialty production capacity.
  • Enhanced Client Satisfaction: Newly installed technical and operational strategy leadership modernized facility performance metrics and communication lines, resulting in significantly enhanced client satisfaction across key sponsor accounts.
  • Improved Quality & Compliance: Unified validation frameworks and lean process improvement protocols led by placed executives successfully eliminated administrative silos, resulting in measurably enhanced quality and regulatory compliance scores.
  • Strong Executive Retention: Placed executives successfully transitioned into their regional facility and corporate roles beyond the critical onboarding period, establishing structural continuity and driving long-term strategic execution.
  • Increased Investor Confidence: Rapid, high-impact executive placement and structured talent onboarding directly reinforced board, institutional investor, and stakeholder confidence in the company’s long-term commercial rollout and facility growth thesis.

Key Outcomes

  • 550+ senior corporate manufacturing, plant engineering, continuous improvement, and site quality executive profiles systematically mapped across leading North American and global life sciences corridors.
  • Successfully placed and integrated a complete executive leadership framework—spanning the Head of Manufacturing Operations, VP of Pharmaceutical Production, and critical plant directors—within a 12-month timeline through a targeted retained search.
  • Unified separate plant operations, laboratory data modeling, and commercial distribution strategy assets under a single, cohesive corporate development strategy by installing process-driven manufacturing leaders.
  • Accelerated new-platform laboratory validation and standardized product lifecycles by placing forward-thinking manufacturing excellence and technical operations executives.
  • Mitigated long-term operational risks and optimized multi-line protocol monitoring frequency by placing specialized, data-driven process improvement and quality operations leaders.
  • Protected crucial production pipelines, sensitive trial data metrics, and source molecular drawings during high-stakes growth phases through strict search confidentiality.
  • Provided board directors, institutional shareholders, and corporate stakeholders with a high-performance management framework explicitly equipped to eliminate international regulatory barriers and drive profitable commercial innovation at scale.

Scaling a Pharmaceutical CDMO or Seeking to Optimize Multi-Facility Production?

JRG Partners helps global contract development and manufacturing organizations, generic drug producers, and specialty life sciences enterprises attract and retain heads of manufacturing, vice presidents of operations, and plant directors who scale precision platforms — discreetly, and with deep technical sector expertise.

Connect with our global pharmaceutical manufacturing and corporate operations search experts today to discuss your mandate.

Connect With Our Sourcing Experts